Mohammad Rehan Ajmal
Overview
Explore the profile of Mohammad Rehan Ajmal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elangeeb M, Elfaki I, Eleragi A, Ahmed E, Mir R, Alzahrani S, et al.
Molecules
. 2024 Apr;
29(8).
PMID: 38675722
Diabetes mellitus (DM) represents a problem for the healthcare system worldwide. DM has very serious complications such as blindness, kidney failure, and cardiovascular disease. In addition to the very bad...
2.
Ajmal M
Diseases
. 2023 Feb;
11(1).
PMID: 36810544
Proteins are central to life functions. Alterations in the structure of proteins are reflected in their function. Misfolded proteins and their aggregates present a significant risk to the cell. Cells...
3.
Almutairi F, Khan A, Ajmal M, Khan R, Khan M, Lal H, et al.
Life (Basel)
. 2022 Dec;
12(12).
PMID: 36556474
The root-knot nematode is one of the most damaging plant-parasitic nematodes and is responsible for significant crop losses worldwide. Rising human health and environmental concerns have led to the withdrawal...
4.
Hashim M, Arif H, Tabassum B, Arif A, Rehman A, Rehman S, et al.
Metabolites
. 2022 Nov;
12(11).
PMID: 36355142
Globally, people are highly affected by Cadmium (Cd), the most hazardous heavy metal. It has been implicated in various pathogeneses. Oxidative stress may be one the main reasons for Cd-induced...
5.
Khan A, Nabi F, Ajmal M, Ali S, Almutairi F, Alalawy A, et al.
ACS Chem Neurosci
. 2022 Aug;
13(16):2529-2539.
PMID: 35930676
The aggregation of Aβ42 is established as a key factor in the development of Alzheimer's disease (AD). Consequently, molecules that inhibit aggregation of peptide may lead to therapies to prevent...
6.
Pramodh S, Raina R, Hussain A, Bagabir S, Haque S, Raza S, et al.
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35409426
Cancer progression is linked to abnormal epigenetic alterations such as DNA methylation and histone modifications. Since epigenetic alterations, unlike genetic changes, are heritable and reversible, they have been considered as...
7.
Zaidi N, Ajmal M, Zaidi S, Khan R
ACS Chem Neurosci
. 2021 Dec;
13(1):69-80.
PMID: 34878262
A variety of neurodegenerative disorders including Parkinson's disease are due to fibrillation in amyloidogenic proteins. The development of therapeutics for these disorders is a topic of extensive research as effective...
8.
On the binding reaction of loratadine with human serum acute phase protein alpha 1-acid glycoprotein
Almutairi F, Ajmal M, Siddiqi M, Alalawy A, Khan R
J Biomol Struct Dyn
. 2021 Jun;
40(19):9484-9491.
PMID: 34121623
Loratadine is an important anti-allergic drug. It is a second generation antihistamine drug used to treat allergic rhinitis, hay fever and urticaria. Human serum alpha 1-acid glycoprotein (AG) is an...
9.
Telles C, Roy A, Ajmal M, Mustafa S, Ahmad M, de la Serna J, et al.
JMIR Public Health Surveill
. 2021 May;
7(5):e30007.
PMID: 33939626
[This corrects the article DOI: 10.2196/20699.].
10.
Telles C, Roy A, Ajmal M, Mustafa S, Ahmad M, de la Serna J, et al.
JMIR Public Health Surveill
. 2021 Mar;
7(4):e20699.
PMID: 33729168
Background: Daily new COVID-19 cases from January to April 2020 demonstrate varying patterns of SARS-CoV-2 transmission across different geographical regions. Constant infection rates were observed in some countries, whereas China...